NCT02188368 2023-11-03Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma PatientsOncotherapeuticsPhase 2 Terminated45 enrolled
NCT03104270 2022-03-31Combination Study for High Risk Multiple Myeloma PatientsOncotherapeuticsPhase 2 Terminated13 enrolled